
    
      OBJECTIVES:

        -  Determine the toxicity and maximum tolerated dose of intratumoral adenoviral
           vector-delivered interleukin-12 gene in patients with liver metastases secondary to
           colorectal cancer .

        -  Determine the tumor response in patients treated with this regimen.

        -  Determine the immune response in patients treated with this regimen.
    
  